Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|October 4, 2005
Inhibition of adipogenesis by RGD-dependent disintegrinYu-Ting Lin, Chih-Hsin Tang, Woei-Jer Chuang, et al.
Thrombosis Research|May 1, 2007
A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in miceChao-Zong Liu, Tur-Fu Huang, Po-Jun Tsai, et al.
European Journal of Pharmacology|March 29, 2026
Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injuryMing-Jen Hsu, Shih-Hsin Hsiao, Jin-Cherng Lien, et al.
Archiv Der Pharmazie|August 23, 2008
Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agentsJin-Cherng Lien, Chi-Rei Wu, Mann-Jen Hour, et al.
Biochemical Pharmacology|November 13, 2012
Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activationChun-Chieh Hsu, Jin-Cherng Lien, Chia-Wen Chang, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 22, 2005
Inhibition of tumor formation by snake venom disintegrinRong-Sen Yang, Chih-Hsin Tang, Woei-Jer Chuang, et al.
Molecular Pharmacology|March 17, 2006
Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblastsChih-Hsin Tang, Rong-Sen Yang, Tsang-Hai Huang, et al.
Neuroscience Letters|September 15, 2004
Inhibition of neuropathic pain by a potent disintegrin--triflavinWen-Mei Fu, Tung-Kai Chang, Wei-Zen Sun, et al.
British Journal of Pharmacology|January 15, 2011
NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entryHeng-Lan Kuo, Jin-Cherng Lien, Chien-Hsin Chang, et al.
British Journal of Pharmacology|August 2, 2019
A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signallingJin-Cherng Lien, Chi-Li Chung, Tur-Fu Huang, et al.
Pageof 6